10 x Genomics收购Proteintech Genomics

2026-06-09 21:17

10x Genomics (TXG) has acquired Proteintech Genomics, the genomics division of Proteintech Group, in a move aimed at expanding its proteomics capabilities.
Financial terms of the deal were not disclosed, and 10x Genomics said the acquisition is not expected to have a material impact on its near-term financial outlook.
Proteintech Genomics brings differentiated technologies, including its Human Discovery Panel, said to be the largest antibody-based single-cell protein panel, designed to support integrated analysis of intracellular proteins, cell surface proteins, and transcriptomic profiles within sequencing-compatible workflows.

More on 10x Genomics